Diane E. Gingrich

1.1k citations
25 papers · 725 · h-index 15

Impact in

  • Oncology top 10%
    • Cytokine Signaling Pathways and Interactions
    • Lung Cancer Research Studies
  • Organic Chemistry top 10%
    • Quinazolinone synthesis and applications

Papers in

  • Molecular Biology 13
    • Chemical Synthesis and Analysis 5
    • Angiogenesis and VEGF in Cancer 3
  • Oncology 11
    • Cytokine Signaling Pathways and Interactions 5
    • Cancer Treatment and Pharmacology 3
Co-authors
Bruce Ruggeri (10 shared papers)Thelma S. Angeles (12 shared papers)Mark S. Albom (11 shared papers)Mark A. Ator (10 shared papers)Bruce D. Dorsey (10 shared papers)Roberta L. Dorow (4 shared papers)Lisa D. Aimone (9 shared papers)Robert L. Hudkins (4 shared papers)
Journals
Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Molecular Cancer Therapeutics (2 papers)Organic Process Research & Development (1 paper)The Journal of Immunology (1 paper)
Partner nations
United StatesItalyJapan

In The Last Decade

Diane E. Gingrich

25 papers receiving 679 citations

Peers

Diane E. Gingrich
Comparison fields: 5 of 82
  • Oncology 248
  • Organic Chemistry 237
  • Toxicology 22
  • Molecular Biology 352
  • Genetics 49
Replace Peter Drueckes with:
Peter Drueckes Switzerland
Hisao Fukumoto Japan
Vito Guagnano Switzerland
Rémy Morgentin France
Manuela Gridling Austria
Francis X. Tavares United States
Darcy Bates United States
Kenji Hirotani Japan
Kazuhide Nakamura Japan
Yibin Zeng United States
Diane E. Gingrich relative to Peter Drueckes Switzerland Peter Drueckes's profile →
Citations per field
00.5×1.5×
Peter Drueckes · 1×
Citations per year

Countries citing papers authored by Diane E. Gingrich

Since Specialization
Citations

This map shows the geographic impact of Diane E. Gingrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane E. Gingrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane E. Gingrich more than expected).

Fields of papers citing papers by Diane E. Gingrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane E. Gingrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane E. Gingrich. The network helps show where Diane E. Gingrich may publish in the future.

Co-authors

The 25 scholars most cited alongside Diane E. Gingrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diane E. Gingrich Line = papers co-authored together Diane E. Gingrich links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Current Medicinal Chemistry ·T. L. UNDERINER, Bruce Ruggeri, Diane E. Gingrich
2004114
2
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis
Arthritis Research & Therapy ·Kristine L. Stump, Lily Lu, Paweł Dobrzański, Cynthia Serdikoff, Diane E. Gingrich, Benjamin J. Dugan, Thelma S. Angeles, Mark S. Albom, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Matthew M. Seavey
201167
3
A New Class of Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors:  Structure−Activity Relationships for a Series of 9-Alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-ones and the Identification of CEP-5214 and Its Dimethylglycine Ester Prodrug Clinical Candidate CEP-7055
Journal of Medicinal Chemistry ·Diane E. Gingrich, D. Rajagopala Reddy, Mohamed Iqbal, (unknown), Lisa D. Aimone, Thelma S. Angeles, Mark S. Albom, Shi Yang, Mark A. Ator, Sheryl L. Meyer, Candy Robinson, Bruce Ruggeri, Craig A. Dionne, Jeffry L. Vaught, John P. Mallamo, Robert L. Hudkins
200366
4
CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers
Molecular Cancer Therapeutics ·Mangeng Cheng, Matthew R. Quail, Diane E. Gingrich, Gregory R. Ott, Lihui Lü, Weihua Wan, Mark S. Albom, Thelma S. Angeles, Lisa D. Aimone, Flavio Cristofani, Rodolfo Machiorlatti, Cristina Abele, Mark A. Ator, Bruce D. Dorsey, Giorgio Inghirami, Bruce Ruggeri
201163
5
Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2
The Journal of Immunology ·Lily Lu, Kristine L. Stump, Nate H. Wallace, Paweł Dobrzański, Cynthia Serdikoff, Diane E. Gingrich, Benjamin J. Dugan, Thelma S. Angeles, Mark S. Albom, Jennifer L. Mason, Mark A. Ator, Bruce D. Dorsey, Bruce Ruggeri, Matthew M. Seavey
201162
6
A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-a]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779
Journal of Medicinal Chemistry ·Benjamin J. Dugan, Diane E. Gingrich, Eugen F. Mesaros, Karen L. Milkiewicz, Matthew A. Curry, Allison L. Zulli, Paweł Dobrzański, Cynthia Serdikoff, Mahfuza Jan, Thelma S. Angeles, Mark S. Albom, Jennifer L. Mason, Lisa D. Aimone, Sheryl L. Meyer, Zeqi Huang, Kevin J. Wells‐Knecht, Mark A. Ator, Bruce Ruggeri, Bruce D. Dorsey
201256
7
2,7-Disubstituted-pyrrolo[2,1-f][1,2,4]triazines: New Variant of an Old Template and Application to the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors with in Vivo Antitumor Activity
Journal of Medicinal Chemistry ·Gregory R. Ott, Gregory J. Wells, Tho V. Thieu, Matthew R. Quail, Joseph G. Lisko, Eugen F. Mesaros, Diane E. Gingrich, Arup K. Ghose, Weihua Wan, Lihui Lü, Mangeng Cheng, Mark S. Albom, Thelma S. Angeles, Zeqi Huang, Lisa D. Aimone, Mark A. Ator, Bruce Ruggeri, Bruce D. Dorsey
201136
8
Discovery of an Orally Efficacious Inhibitor of Anaplastic Lymphoma Kinase
Journal of Medicinal Chemistry ·Diane E. Gingrich, Joseph G. Lisko, Matthew A. Curry, Mangeng Cheng, Matthew R. Quail, Lihui Lü, Weihua Wan, Mark S. Albom, Thelma S. Angeles, Lisa D. Aimone, R. Curtis Haltiwanger, Kevin J. Wells‐Knecht, Gregory R. Ott, Arup K. Ghose, Mark A. Ator, Bruce Ruggeri, Bruce D. Dorsey
201233
9
Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease
Drug Development Research ·Mary J. Savage, Diane E. Gingrich
200929
10
A Novel Preparation of Scalemic N-Methyl-.alpha.-Amino Acids
The Journal of Organic Chemistry ·Roberta L. Dorow, Diane E. Gingrich
199527
11
Development and Scale-Up of an Optimized Route to the ALK Inhibitor CEP-28122
Organic Process Research & Development ·Shawn P. Allwein, Renee C. Roemmele, James J. Haley, Dale R. Mowrey, Daniel E. Petrillo, James J. Reif, Diane E. Gingrich, Roger P. Bakale
201127
12
Antineoplastic agents. Part 395.1 Isolation and structure of agelagalastatin from the Papua New Guinea marine sponge Agelas sp.
Chemical Communications ·George R. Pettit, Jun‐Ping Xu, Diane E. Gingrich, Michael D. Williams, Dennis L. Doubek, Jean‐Charles Chapuis, Jean M. Schmidt
199920
13
Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases
Bioorganic & Medicinal Chemistry Letters ·Craig A. Zificsak, Diane E. Gingrich, Henry J. Breslin, Derek Dunn, Karen L. Milkiewicz, Jay Theroff, Tho V. Thieu, Ted L. Underiner, Linda R. Weinberg, Lisa D. Aimone, Mark S. Albom, Jennifer L. Mason, Lisa Saville, Jean Husten, Thelma S. Angeles, James P. Finn, Mahfuza Jan, Teresa M. O’Kane, Paweł Dobrzański, Bruce D. Dorsey
201118
14
Synthesis, Modeling, and In Vitro Activity of (3‘S)-epi-K-252a Analogues. Elucidating the Stereochemical Requirements of the 3‘-Sugar Alcohol on trkA Tyrosine Kinase Activity
Journal of Medicinal Chemistry ·Diane E. Gingrich, Shi Yang, George Gessner, Thelma S. Angeles, Robert L. Hudkins
200518
15
2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: Modification of target structure to minimize reactive metabolite formation
Bioorganic & Medicinal Chemistry Letters ·Linda R. Weinberg, Mark S. Albom, Thelma S. Angeles, Henry J. Breslin, Diane E. Gingrich, Zeqi Huang, Joseph G. Lisko, Jennifer L. Mason, Karen L. Milkiewicz, Tho V. Thieu, Ted L. Underiner, Gregory J. Wells, Kevin J. Wells‐Knecht, Bruce D. Dorsey
201117
16
Synthesis and kinase inhibitory activity of 3′-(S)-epi-K-252a
Bioorganic & Medicinal Chemistry Letters ·Diane E. Gingrich, Robert L. Hudkins
200214
17
Inhibition of metalloproteinase by futoenone derivatives
Bioorganic & Medicinal Chemistry Letters ·Li-An Yeh, James Chen, Frans Baculi, Diane E. Gingrich, T. Y. Shen
199514
18
A comparison of the determination and speciation of inorganic arsenic using general HPLC methodology with UV, MS and MS/MS detection
Journal of Chromatography B ·Gregory Gilmartin, Diane E. Gingrich
201813
19
A novel, one-pot preparation ofN-methyl-α-amino acid dipeptides from oxazolidinones and amino acids
Tetrahedron Letters ·Roberta L. Dorow, Diane E. Gingrich
199911
20
2,7-Disubstituted-Pyrrolotriazine Kinase Inhibitors with an Unusually High Degree of Reactive Metabolite Formation
Chemical Research in Toxicology ·Kevin J. Wells‐Knecht, Gregory R. Ott, Mangeng Cheng, Gregory J. Wells, Henry J. Breslin, Diane E. Gingrich, Linda R. Weinberg, Eugen F. Mesaros, Zeqi Huang, Mehran Yazdanian, Mark A. Ator, Lisa D. Aimone, Kelli S. Zeigler, Bruce D. Dorsey
20118

About Diane E. Gingrich

Diane E. Gingrich is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Genetics and Neurology, having authored 25 papers that have together received 725 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Neuroblastoma Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Click Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (248 citations), Organic Chemistry (237 citations), Toxicology (22 citations), Molecular Biology (352 citations) and Genetics (49 citations). Diane E. Gingrich has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Bruce Ruggeri, Thelma S. Angeles, Mark S. Albom, Mark A. Ator, Bruce D. Dorsey, Roberta L. Dorow, Lisa D. Aimone, Robert L. Hudkins, Mary J. Savage and Paweł Dobrzański. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, Organic Process Research & Development and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter DrueckesBreakdown of academic impact, for papers by Hisao FukumotoBreakdown of academic impact, for papers by Vito GuagnanoBreakdown of academic impact, for papers by Rémy MorgentinBreakdown of academic impact, for papers by Manuela GridlingBreakdown of academic impact, for papers by Francis X. TavaresBreakdown of academic impact, for papers by Darcy BatesBreakdown of academic impact, for papers by Kenji HirotaniBreakdown of academic impact, for papers by Kazuhide NakamuraBreakdown of academic impact, for papers by Yibin Zeng